[1]
F. Sorà, “IS ALLOGENEIC TRANPLANTATION AN OPTION IN PATIENTS AFFECTED BY CONCURRENT MYELOFIBROSIS AND CHRONIC MYELOID LEUKEMIA (CML)?”, Mediterr J Hematol Infect Dis, vol. 13, no. 1, p. e2021062, Oct. 2021.